BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2004
View Archived Issues
Sepracor highlights year-end 2003 progress
Read More
T-0901317 induces severe lipogenesis in diabetic mice
Read More
Novel selective cytokine inhibitory drugs demonstrate enhanced antiangiogenic activity
Read More
Novel protease inhibitor SM-322377 active against multidrug-resistant HIV variants
Read More
Cleveland Clinic and Ricerca to develop cobalamin-based anticancer compound
Read More
SU-11248 inhibits tumor growth and osteolysis in a human breast cancer bone metastasis model
Read More
Altana researchers present two novel series of PARP-1 inhibitors
Read More
Procter & Gamble claims ICE inhibitors for bone disorders and other uses
Read More
GSK scientists identify new cathepsin K/falcipain inhibitors
Read More
Takeda patent covers novel tachykinin antagonists with utility in urinary disorders
Read More
New antitumor agents developed by RIKEN scientists
Read More
NO-containing COX-2 inhibitors in early development at NitroMed
Read More
Glycine transport inhibitors from bacterial source and their use in ataxia
Read More
Merck and Jerini to develop small molecule inhibitors for cancer
Read More
Tanabe gains Japanese rights to prasterone
Read More
Pfizer submits sNDA for Geodon product label changes
Read More
NeoRx receives payment from Boston Scientific
Read More
Rapid absorption, high plasma concentrations in phase I nasal fentanyl study
Read More
Activa Therapy more effective than pallidotomy in Parkinson's patients
Read More
Betaseron prefilled diluent syringe launched in U.S.
Read More
Phase III Thymitaq trial cleared to continue by DSMB
Read More
Lilly reacts to opinion paper on antipsychotic drugs in obesity and diabetes
Read More
Initial proof-of-concept study successfully completed for Provasca
Read More
Rigel reports on the progress of R-803, R-406
Read More
European orphan drug status for sildenafil for PAH
Read More
Provectus prepares IND filing for Provecta
Read More
Launch of Zoderm acne treatment
Read More
Xcytrin enters phase I trial in combination with Temodar for glioma
Read More
Viral Therapeutics acquires development rights to Virusorb
Read More
Lipid profile improvements found with D-003 in patients with type II hypercholesterolemia
Read More